Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (601-610 of 706) with videos related to

Pageof 71
Sort By:
Circulation|December 21, 2018
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.
Circulation|September 1, 2010
Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trialStefan James, Andrzej Budaj, Philip Aylward, et al.
Diabetes, Obesity & Metabolism|June 19, 2024
Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trialKathryn Cardoza, Amy Kang, Brendan Smyth, et al.
JACC. Cardiovascular Interventions|April 7, 2021
Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI TrialBenjamin E Peterson, Deepak L Bhatt, Ph Gabriel Steg, et al.
Journal of the American College of Cardiology|September 30, 2017
Physical Activity and Mortality in Patients With Stable Coronary Heart DiseaseRalph A H Stewart, Claes Held, Nermin Hadziosmanovic, et al.
Journal of the American College of Cardiology|February 25, 2017
Atherothrombotic Risk Stratification and Ezetimibe for Secondary PreventionErin A Bohula, David A Morrow, Robert P Giugliano, et al.
Clinical Cardiology|February 7, 2026
Rationale and Design of the Cooperative Program for ImpLementation of Optimal Therapy in Heart FailureAlexander J Blood, Ozan Unlu, John W Ostrominski, et al.
Lancet (London, England)|January 19, 2010
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind studyChristopher P Cannon, Robert A Harrington, Stefan James, et al.
JAMA|July 3, 2008
Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysisMichelle O'Donoghue, William E Boden, Eugene Braunwald, et al.
The American Journal of Cardiology|May 15, 2003
Time for contrast material to traverse the epicardial artery and the myocardium in ST-segment elevation acute myocardial infarction versus unstable angina pectoris/non-ST-elevation acute myocardial infarctionGraham C Wong, Daniel Frisch, Sabina A Murphy, et al.
Pageof 71

Showing results (601-610 of 706) with videos related to

Sort By:
Pageof 71
Circulation|December 21, 2018
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.
Circulation|September 1, 2010
Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trialStefan James, Andrzej Budaj, Philip Aylward, et al.
Diabetes, Obesity & Metabolism|June 19, 2024
Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trialKathryn Cardoza, Amy Kang, Brendan Smyth, et al.
JACC. Cardiovascular Interventions|April 7, 2021
Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI TrialBenjamin E Peterson, Deepak L Bhatt, Ph Gabriel Steg, et al.
Journal of the American College of Cardiology|September 30, 2017
Physical Activity and Mortality in Patients With Stable Coronary Heart DiseaseRalph A H Stewart, Claes Held, Nermin Hadziosmanovic, et al.
Journal of the American College of Cardiology|February 25, 2017
Atherothrombotic Risk Stratification and Ezetimibe for Secondary PreventionErin A Bohula, David A Morrow, Robert P Giugliano, et al.
Clinical Cardiology|February 7, 2026
Rationale and Design of the Cooperative Program for ImpLementation of Optimal Therapy in Heart FailureAlexander J Blood, Ozan Unlu, John W Ostrominski, et al.
Lancet (London, England)|January 19, 2010
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind studyChristopher P Cannon, Robert A Harrington, Stefan James, et al.
JAMA|July 3, 2008
Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysisMichelle O'Donoghue, William E Boden, Eugene Braunwald, et al.
The American Journal of Cardiology|May 15, 2003
Time for contrast material to traverse the epicardial artery and the myocardium in ST-segment elevation acute myocardial infarction versus unstable angina pectoris/non-ST-elevation acute myocardial infarctionGraham C Wong, Daniel Frisch, Sabina A Murphy, et al.
Pageof 71